about
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility lociDense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitisSmall duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis.Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitisInflammation But Not Biliary Obstruction Is Associated With Carbohydrate Antigen 19-9 Levels in Patients With Primary Sclerosing Cholangitis.The Influence of the Autoimmunity-Associated Ancestral HLA Haplotype AH8.1 on the Human Gut Microbiota: A Cross-Sectional Study.Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART.Gut microbiota diversity predicts immune status in HIV-1 infection.Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing CholangitisExtended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.TGR5 sequence variation in primary sclerosing cholangitis.Genetics in primary sclerosing cholangitis.A common genetic variant of fucosyltransferase 2 correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis.Genome-wide association analysis in primary sclerosing cholangitis.Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing CholangitisThe gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.Personalised medicine targeting the gut microbiota?Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis.Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis.[Wasp allergy vaccination].Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires.Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.Agreement of a child's respiratory symptom diary with parental reports and peak expiratory flow.Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction.FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitisAutotaxin activity predicts transplant-free survival in primary sclerosing cholangitis.Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-CPNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survivalEditorial: proton pump inhibition - microbial complications beyond dysbiosisGut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida speciesGut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trialCirculating markers of gut barrier function associated with disease severity in primary sclerosing cholangitisThe gut microbial influence on cholestatic liver diseaseClinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels
P50
Q28943478-5AB1BB50-5B06-46E2-B50F-7404032B7BD9Q30416155-E83ED72F-D784-4FAD-A11E-012FC2AD7A05Q33682175-0C2EE9F8-0620-466D-B695-981E34969B1BQ34028662-EC6EC081-BB7C-4527-A833-27C70A104FE0Q34626025-EABB931C-AD5A-4BC3-ABC6-67387244A495Q35083983-A3EAF007-48DF-4D38-BAAE-2CEA87E6C307Q35698336-FD56D801-FA0C-4232-84FD-DE7D99C63764Q35710401-2C736480-BAFC-434E-9035-395E1AD55512Q35741375-62A059C8-9932-42CB-B765-C163AED9FB4EQ35768934-91A66F93-55CA-41B8-8DF8-2FCB71C8A18CQ35829727-5AB59873-A3B5-43D3-B840-37D2A80A9EF4Q36101099-3D17997F-30B3-42FD-9621-EE77AE2D346FQ36468290-E227522F-DA5B-43AA-9418-E4625670C3D2Q36827878-F152E3EB-7F6C-4CCC-A426-633371535C57Q37697560-EDA851E3-AA23-41A2-B959-0086F7A9CBBCQ37892289-57464B42-13EF-410E-AA9F-2BF3E82A699EQ38007271-0A1806E4-1B53-48F8-8C1F-481FF3472318Q38623360-B9134E5B-DDF7-4BDC-B58A-7FF8729FF703Q39769745-8B45212F-AF00-46C7-B1E6-BB3E79DB0970Q39950579-CB1BB524-C491-4728-86A7-37E050D23F6CQ40787355-FD7A6561-02D0-4D87-B8F4-E266304612E9Q46739517-53049543-DDB8-4C24-BD37-FDEC40537C2EQ50768780-C7F5E03C-24D3-4490-A4C3-9317C3F7D352Q50939070-A1A94D37-1B1A-4501-BA12-DBC11B3E1294Q52606269-DBE6EF2C-F68B-45D4-8FB4-D158C8B64DD6Q52885250-5DB2F177-CF58-481A-8494-829553D7FAC2Q52925804-5319B3E0-CC1A-4D46-98DF-5D11709587B9Q52934499-0520D29A-6CF8-4E74-975B-67A5EA5F36FEQ53053246-F37F69EA-1FCD-4796-BDEA-5EE24DA98F18Q54224356-DCC34E9F-3E5B-495C-964C-852B55787912Q57155136-00FCFA33-4529-4E88-9D76-A5DE2D42ED41Q64988395-5BACB79C-F04D-44E0-8921-F47668FFD714Q83936677-2650774D-38FD-4AA9-8EE3-1704E377DABAQ85661035-A186006F-A73D-4CAC-868C-05A7FF03289DQ90578311-C5435E4E-196A-4820-BD8B-E82610D9BE14Q90949889-EE8F9684-8A6D-43C4-B5AC-FFE2B2C8D9F3Q91673342-471A8F34-D91D-4209-A60D-A29C064F103EQ91890521-DB529C42-A74B-4003-9C8C-69744787CAB3Q92270923-713C481E-6C88-4EF5-AD91-0AD4D65CF33FQ92695235-5FD1F306-0CCC-4C57-AD0F-AE7ADC0DFAC5
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Johannes Roksund Hov
@ast
Johannes Roksund Hov
@en
Johannes Roksund Hov
@es
Johannes Roksund Hov
@nl
Johannes Roksund Hov
@sl
type
label
Johannes Roksund Hov
@ast
Johannes Roksund Hov
@en
Johannes Roksund Hov
@es
Johannes Roksund Hov
@nl
Johannes Roksund Hov
@sl
altLabel
Johannes Hov
@en
prefLabel
Johannes Roksund Hov
@ast
Johannes Roksund Hov
@en
Johannes Roksund Hov
@es
Johannes Roksund Hov
@nl
Johannes Roksund Hov
@sl
P1015
P1015
P106
P21
P214
39145970211432251616
P31
P496
0000-0002-5900-8096
P569
1977-01-01T00:00:00Z